Characterizing the Use of Botulinum Toxin in Patients with Hirschsprung Disease Treated at Referral Institutions for Pediatric Colorectal Surgery
Author / Expert
Samuel E. Rice-Townsend, Lauren Nicassio, Debra Glazer, Jeffrey Avansino, Megan M Durham, Casey M. Calkins, Rebecca M Rentea, Matthew W Ralls, Richard J Wood, Michael D Rollins, Erin M Garvey, Katelyn E Lewis, Ron Reeder, Caitlin A Smith, Pediatric Colore
Topic overview
ABSTRACT
Purpose
: Botulinum toxin (BT) is used to treat pediatric patients with Hirschsprung disease (HD) with obstructive symptoms. We aimed to characterize use of BT in HD patients across pediatric colorectal surgery referral centers.
Methods
: A multicenter retrospective study of BT use in children (0-18y) with HD was performed using the Pediatric Colorectal and Pelvic Learning Consortium (PCPLC) between 2017-2021. Sites with
Comments